OVERVIEW

Tesamorelin, CJC-1295 (no DAC), and Ipamorelin 12mg (blend) is a combination of peptides designed to naturally stimulate growth hormone production in the body. Tesamorelin is a synthetic growth hormone–releasing hormone (GHRH) analog that signals the pituitary gland to release growth hormone in a pulsatile and physiologically regulated manner. CJC-1295 (no DAC) is another GHRH analog that promotes growth hormone secretion but without the long-acting drug affinity complex (DAC), allowing for shorter, controlled pulses. Ipamorelin is a selective growth hormone–releasing peptide (GHRP) that acts on ghrelin receptors to further enhance growth hormone output while minimizing effects on cortisol and prolactin. When combined in a 12mg formulation, these peptides work synergistically to optimize endogenous growth hormone release, supporting recovery, metabolism, and tissue regeneration.

This 12mg blend is typically supplied as a lyophilized powder intended for research or experimental use and requires reconstitution before administration. Preclinical studies and anecdotal reports suggest it may support lean muscle development, fat metabolism, improved sleep, and enhanced recovery from exercise or injury. Potential side effects are generally mild, including water retention, tingling sensations, or increased appetite. As the blend acts on hormonal pathways, it is not approved for general medical use, and careful supervision by a qualified healthcare professional is strongly recommended to ensure safe dosing and monitoring of effects.